|
anti-von Willebrand Factor, monoclonal antibodies |
|
|
|
|
|
autologous cellular products |
|
|
|
|
|
benzamides |
|
benzimidazoles |
|
benzimidazoles, nonsteroidal anti-inflammatory drugs (NSAIDs), proton pump inhibitors |
|
|
|
|
|
benzofurans |
|
|
|
beta-adrenergic agonists, anticholinergics |
|
|
|
beta blockers (selective) |
|
biguanides |
|
bile acid replacements |
|
|
|
biologic response modifiers |
|
|
|
blood products, colloids |
|
bradykinin B2 receptor antagonists |
|
|
|
|
|
butyrophenones, dopamine antagonists |
|
|
|
|
|
|
|
calcium channel blockers (dihydropyridine) |
